Sort
85,873 grants matching “alzheimers”
Molecular Diversity Among Hippocampal and Entorhinal Cells in Aging and Alzheimer's Disease
$1,536,271Nenad Sestan · Yale University · R01 · FY2025 · AG
Joint Estimate Diffusion Imaging (JEDI) for improved Tissue Characterization and Neural Connectivity in Aging and Alzheimer's Disease
$1,536,095Lawrence R. Frank · University Of California, San Diego · R01 · FY2025 · AG
Functional and cell-type specific axonal pathways in the primate brain
$1,535,708R Clay Reid · Allen Institute · UG3 · FY2021 · MH
A Novel Algorithm to Identify People with Undiagnosed Alzheimer's Disease and Related Dementias
$1,535,530Cynthia Louise Benjamin · Together Senior Health, Inc. · R44 · FY2023 · AG
Pathologic protein folding and human disease
$1,535,302David B. Teplow · University Of California Los Angeles · P01 · FY2009 · AG
Medical Scientist Training Program
$1,535,030Kevin M Shannon · University Of California, San Francisco · T32 · FY2011 · GM
Interdisciplinary Approach to Alzheimer Drug Discovery
$1,535,008Samuel E Gandy · Icahn School Of Medicine At Mount Sinai · P01 · FY2008 · AG
IND Enabling Studies for a Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Alzheimer's Disease Related Dementia
$1,535,000Meredith Hay · University Of Arizona · U01 · FY2023 · AG
NEUROBIOLOGY OF ALZHEIMER'S DISEASE AND AGING
$1,534,318University Of Texas Sw Med Ctr/Dallas · P30 · FY2004 · AG
The United States Cost of Dementia Model: Quantifying Current and Future Impacts of Alzheimerâs Disease and Related Dementias
$1,534,001Julie M Zissimopoulos · University Of Southern California · U01 · FY2025 · AG
The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study
$1,533,982Joe Verghese · Albert Einstein College Of Medicine · R01 · FY2022 · AG
AI models of multi-omic data integration for ming longevity core signaling pathways
$1,533,939Fuhai Li · Washington University · R33 · FY2025 · AG
PHASE II/III trial for Slowing Progression in Mild Cognitive Impairment
$1,533,694Michela Gallagher · Johns Hopkins University · R01 · FY2017 · AG
p53, Aging, and Cancer
$1,533,497Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Immune Mechanisms Underlying the Neuroprotective Effects of Physical Activity in Human and Mouse Models of Genetic Risk for Alzheimers Disease
$1,533,181Stephen Mark Rao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · AG
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
$1,533,089Kathleen E. Rodgers · University Of Arizona · U01 · FY2020 · AG
Epidemiology of Brain Aging in the Very Old
$1,533,073Lon Ray White · Kuakini Medical Center · U01 · FY2008 · AG
Cognitive Heterogeneity in those with high Alzheimer's Disease Risk
$1,532,717Rhoda Au · Boston University Medical Campus · RF1 · FY2020 · AG
Preclinical Evaluation Of PET Radiotracers
$1,532,574Robert Innis · National Institute Of Mental Health · Z01 · FY2007 · MH
Expanding F-18 Production for PET/CT
$1,532,485Bruce Wendell Wieland · Bruce Technologies, Inc. · RC3 · FY2010 · RR
Neuropeptides and Carboxypeptidase E/ Neurotrophic Factor-alpha1 in Neural and Cognitive Functions
$1,532,434Y. Peng Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Multimodal in Vivo and Postmortem Analysis of ARIA-Relevant Pathophysiology
$1,531,729Julia K Kofler · University Of Pittsburgh At Pittsburgh · U24 · FY2025 · NS
GESTALT-Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing
$1,531,622Luigi Ferrucci · National Institute On Aging · ZIA · FY2018 · AG
Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's disease
$1,531,573David Weinshenker · Emory University · RF1 · FY2022 · AG
A novel mechanism for NLRP3 inflammasome activation in human macrophages
$1,531,430Christian Stehlik · Cedars-Sinai Medical Center · R01 · FY2025 · AI